Page last updated: 2024-09-04

ciladopa and Parkinson Disease

ciladopa has been researched along with Parkinson Disease in 8 studies

*Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) [MeSH]

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lang, AE	1
Berger, J; Factor, SA; Sanchez-Ramos, J; Weiner, WJ	1
Aminoff, MJ; Goodin, DS	1
Snider, SR	1
Berger, JR; Weiner, WJ	1
Goldstein, M; Gopinathan, G; Lieberman, A; Neophytides, A; Pasternack, P	1
Aminoff, MJ; Cutler, JR; Goodin, DS; Habermann-Little, B	1
Fields, JZ; Gordon, JH; Koller, WC; Perlow, MJ	1

Reviews

1 review(s) available for ciladopa and Parkinson Disease

Article	Year
Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine". The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:3 Suppl Topics: Antiparkinson Agents; Bromocriptine; Dopamine; Ergolines; Humans; Parkinson Disease; Piperazines	1987

Trials

3 trial(s) available for ciladopa and Parkinson Disease

Article	Year
A double-blind evaluation of ciladopa in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:3 Topics: Aged; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Piperazines; Random Allocation	1987
Effect of ciladopa on Parkinson's disease: a preliminary report. Advances in neurology, 1987, Volume: 45 Topics: Aged; Antiparkinson Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Motor Skills; Parkinson Disease; Piperazines	1987
Advanced Parkinson's disease: use of partial dopamine agonist, ciladopa. Neurology, 1987, Volume: 37, Issue:5 Topics: Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Piperazines; Placebos; Random Allocation	1987

Other Studies

4 other study(ies) available for ciladopa and Parkinson Disease

Article	Year
PD and ciladopa. Neurology, 1988, Volume: 38, Issue:1 Topics: Antiparkinson Agents; Humans; Parkinson Disease; Piperazines	1988
More on ciladopa. Annals of neurology, 1987, Volume: 22, Issue:4 Topics: Humans; Parkinson Disease; Piperazines	1987
Treatment of Parkinson's disease with ciladopa. Annals of neurology, 1987, Volume: 21, Issue:3 Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Parkinson Disease; Piperazines	1987
Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug. Neuropharmacology, 1986, Volume: 25, Issue:9 Topics: alpha-Methyltyrosine; Animals; Apomorphine; Body Temperature; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Haloperidol; Male; Methyltyrosines; Parkinson Disease; Piperazines; Rats; Rats, Inbred Strains; Reserpine; Stereotyped Behavior	1986